Akebia Therapeutics
AKBA
#6389
Rank
โ‚น51.71 B
Marketcap
โ‚น197.97
Share price
1.75%
Change (1 day)
73.39%
Change (1 year)

Earnings for Akebia Therapeutics (AKBA)

Earnings in 2024 (TTM): -โ‚น5.85 Billion

According to Akebia Therapeutics's latest financial reports the company's current earnings are โ‚น0.16 Billion. a decrease over its 2023 earnings that were of -โ‚น4.44 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Akebia Therapeutics from 2013 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚น5.93 Billion33.68%
2023 -โ‚น4.44 Billion-45.12%
2022 -โ‚น8.08 Billion-66.55%
2021 -โ‚น24.14 Billion-26.24%
2020 -โ‚น32.73 Billion33.94%
2019 -โ‚น24.43 Billion66.52%
2018 -โ‚น14.68 Billion123.53%
2017 -โ‚น6.57 Billion-43.34%
2016 -โ‚น11.59 Billion123.58%
2015 -โ‚น5.19 Billion63.95%
2014 -โ‚น3.17 Billion181.24%
2013 -โ‚น1.13 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚น393.29 B-6,740.25%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.163 T-19,751.35%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚น1.488 T-25,228.94%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น10.18 Billion 71.73%๐Ÿ‡บ๐Ÿ‡ธ USA